Bookmark and Share

Select Criteria: Tracks = Industry Workshop Theater

Tuesday, August 02, 9:45 AM - 10:45 AM

  • Room: Theater 2
  • Session Number:T07
Mass spec is a key factor in developing a UDT laboratory operation.  Validation is often discussed in terms of the LC-MS.  Both topics often lead to a misunderstanding of what is really involved in establishing a Laboratory Developed Test.  Quasar’s experiences illustrate that a better understanding can greatly reduce the... ...read more...
Speaker(s)
Moderator
Lauren Dostillio
Marketing Communications Specialist
Agilent Technologies
Speaker
Scott Kephart
Tracks:
Sponsored by: Agilent Technologies

    Tuesday, August 02, 10:15 AM - 11:15 AM

    • Room: Theater 1
    Hypophosphatasia (HPP) is a devastating, rare disease that affects patients of all ages, for which a therapy is now available.  Low alkaline phosphatase is the biochemical hallmark of HPP.  This session will describe the relationship between low ALP and HPP, and especially for children, the importance of using appropriately age... ...read more...
    Speaker(s)
    Speaker
    Jeremy Franklin MD, MPH, MBA, FAAP
    Alexion Pharmaceuticals
    Speaker
    Lauren Renna
    Alexion Pharmaceuticals
    Tracks:

      Tuesday, August 02, 12:00 PM - 1:00 PM

      • Room: Theater 1
      • Session Number:T06
      LabLeaders was created with the goal of redefining the value of the laboratory.  Early in 2016, AACC & LabLeaders came together to make this goal a reality through an interactive roundtable focused on providing key insights into how healthcare reform and ACOs impact the labs of today and tomorrow? Want... ...read more...
      Speaker(s)
      Moderator
      Amanda Bos
      Roche Diagnostics Corporation
      Speaker
      Michael Astion MD, PhD
      University of Washington and Seattle Children's Hospital
      Speaker
      Patricia Jones
      Children's Medical Center
      Speaker
      Rusty Ring
      VP of Government Affairs
      Tracks:

        Tuesday, August 02, 1:45 PM - 2:45 PM

        • Room: Theater 1
        • Session Number:T03
        Identification of novel pathogens drives innovation in laboratory diagnostics and has a tremendous impact on human health.  This workshop will focus on the recent development of metagenomic approaches for pathogen discovery utilizing next-generation sequencing (NGS) and pan-viral DNA array technology.  In contrast to currently available diagnostics tests, narrowly targeted to... ...read more...
        Speaker(s)
        Moderator
        Candice Oldenburg PhD
        Abbott
        Speaker
        Dr.  John Hackett
        Abbott Diagnostics
        Tracks:
        Sponsored by: Abbott Laboratories
        • Theater Industry Workshop

        Tuesday, August 02, 2:45 PM - 3:45 PM

        • Room: Theater 2
        This session will include an overview of different methodologies to detect APS antibodies as well as new biomarkers and their clinical utility. ...
        Speaker(s)
        Speaker
        Geoffrey Wool MD, PhD
        University of Chicago, Department of Pathology, Coagulation Laboratory
        Moderator
        Kaz Nakanishi
        Tradeshow Coordinator
        INOVA Diagnostics, Inc.
        Speaker
        Laura Maria Bertolaccini
        Lupus Journal
        Tracks:
        Sponsored by: Inova Diagnostics

          Tuesday, August 02, 3:30 PM - 4:30 PM

          • Room: Theater 1
          Historically, laboratory automation focused in areas of Chemistry and Hematology where improved TATs and standardized processes enhanced overall lab efficiency.  Until recently, automation of Hemostasis testing was limited to a few routine tests, while automation of a broader range, including specialty Hemostasis testing, was not feasible due to specific sample... ...read more...
          Speaker(s)
          Speaker
          Alberto Gomez
          Instrumentation Laboratory
          Speaker
          ERNESTO CASIS MD, PhD
          Vall d'Hebron University Hospital
          Tracks:

            Wednesday, August 03, 10:15 AM - 11:15 AM

            • Room: Theater 1
            • Session Number:W01
            Session Overview: Background:  Hyperthyroidism affects approximately 1.5% of the worldwide population. Graves’ disease is the most common cause of hyperthyroidism, and accounts for 60 to 80 percent of all cases. It is an autoimmune disorder caused by the thyroid stimulating antibody (TSI), active against the thyroid-stimulating hormone (TSH) receptor, which... ...read more...
            Speaker(s)
            Speaker
            Professor  Damien Gruson
            Laboratory Manager, Laboratory of Clinical Endocrinology
            Cliniques Universitaires
            Tracks:
            Sponsored by: Siemens Healthineers
            • Theater Industry Workshop

            Wednesday, August 03, 11:15 AM - 12:15 PM

            • Room: Theater 2
            Hospital-based clinical laboratories are increasingly moving from serum to plasma samples in order to support improved turn-around times.  However, interferences from pre-analytical variables such as cellular contamination can pose a challenge to reporting accurate results.  During this interactive session, speakers Michael Scott, PhD, of Washington University School of Medicine and... ...read more...
            Speaker(s)
            Speaker
            Martin Fleisher PhD
            Attending Clinical Chemist/Director
            Memorial Sloan-Kettering Cance
            Speaker
            Mitchell G. Scott Ph.D
            Professor of Pathology and Immunology/Co-Medical Director, Clinical Chemistry
            Washington University School of Medicine
            Moderator
            Sol Green PhD
            Director of Medical Affairs
            BD
            Tracks:
            Sponsored by: BD

              Wednesday, August 03, 12:00 PM - 1:00 PM

              • Room: Theater 1
              • Session Number:W01
              Driving clinical decisions with accurate reliable, accurate testing is key to engaging clinicians and improving patient outcomes.  This session will provide examples of how best to accomplish this using Roche Cardiac solutions. ...
              Speaker(s)
              Speaker
              Dr.  Alan Wright
              Roche Diagnostics Corporation
              Moderator
              Dr.  Sri Venkatram
              Roche Diagnostics Corporation
              Tracks:
              Sponsored by: Roche Diagnostics

                Wednesday, August 03, 1:00 PM - 2:00 PM

                • Room: Theater 2
                • Session Number:W03
                Natriuretic peptides play an integral role in the diagnosis of congestive heart failure.  Laboratories today have the ability to choose between NT-proBNP and BNP assays to support the testing needs of their patient population. ...
                Speaker(s)
                Speaker
                Robert Christenson PhD
                University of Maryland School of Medicine
                Tracks:
                Sponsored by: Siemens Healthineers
                • Theater Industry Workshop

                Wednesday, August 03, 1:45 PM - 2:45 PM

                • Room: Theater 1
                • Session Number:W07
                Technological advancements and new reagents have improved the accuracy and turn-around-times in hemostasis testing.  Unfortunately, labs are still challenged with identifying and managing pre-analytical sample issues.  Under-filled sample tubes and samples containing interfering levels of hemolysis, icterus and lipemia are the most common issues.  This workshop will explore these and... ...read more...
                Speaker(s)
                Speaker
                Anne Winkler Md, MSc
                Medical Director
                Instrumentation Laboratories
                Tracks:

                  Wednesday, August 03, 2:45 PM - 3:45 PM

                  • Room: Theater 2
                  • Session Number:W05
                  Indirectly acting oral anticoagulant medications such as warfarin require routine laboratory or near patient test monitoring.  Starting in 2009, direct oral anticoagulants (DOACs) not requiring routine monitoring have been introduced to clinical use for reduction of risk of stroke in atrial fibrillation patients, along with prevention or treatment of deep... ...read more...
                  Speaker(s)
                  Speaker
                  Adam Cuker MD, MS
                  Hospital of the University of Pennsylvania, Penn Comprehensive Hemophilia and Thrombosis
                  Speaker
                  James Boyd Groce PharmD, RPh
                  Campbell University, College of Pharmacy and Health Sciences
                  Moderator
                  Paul Riley PhD, MBA
                  Scientific Business Development Manager
                  Diagnostica Stago, Inc.
                  Tracks:
                  • Theater Industry Workshop

                  Wednesday, August 03, 3:30 PM - 4:30 PM

                  • Room: Theater 1
                  • Session Number:W06
                  Introduction to Key Factors in Special Protein Testing – Latest trends in special protein testing and Innovation in special protein testing.  Experience at Laboratory A – Data and observations, to include: workflow, ease of use.   Experience at Laboratory B – Data and observations, to include: efficiency, overall cost. ...
                  Speaker(s)
                  Speaker
                  Kimberly Pacella MT(ASCP) QCYM
                  Health Network Laboratories
                  Speaker
                  Prof. Dr.  Koen Poesen
                  University of Lueven
                  Speaker
                  Stephen Stone
                  Argent Global Services
                  Speaker
                  Thomas Koshy Ph.D.
                  Executive Director Scientific Affairs
                  Binding Site Inc.
                  Tracks:
                  Sponsored by: Binding Site Inc.

                    Thursday, August 04, 11:30 AM - 12:30 PM

                    • Room: Theater 1
                    • Session Number:Th02
                    Presentation 1: Measuring Direct Oral Anticoagulants in the Laboratory A number of novel, oral anticoagulant agents have been introduced recently. These include both direct thrombin and direct factor Xa inhibitors. The impact of these new agents on different activated partial thromboplastin time and prothrombin time reagents and the utility of these... ...read more...
                    Speaker(s)
                    Speaker
                    Dorothy Adcock MD
                    Medical and Laboratory Director
                    Esotrix Hemex
                    Moderator
                    Larry Smith PhD
                    Global Scientific Affairs Manager
                    Abbott Hematology
                    Speaker
                    Steven Marionneaux MS, MT(ASCP)SH
                    Manager Global Scientific Leadership
                    Abbott Hematology
                    Tracks:
                    Sponsored by: Abbott Laboratories
                    • Theater Industry Workshop

                     

                    •  
                      • AACC Annual Scientific Meeting & Clinical Lab Expo Management
                      • SPARGO, Inc.
                      • Toll Free (800) 564-4220
                      • Phone:  (703) 631-6200
                      • Fax (703) 563-2691
                      • Email:  aaccexhibits@spargoinc.com
                    •